Study of the Safety and Tolerability of Switching to ITCA 650 in Patients With Type 2 Diabetes Receiving Liraglutide
Public ClinicalTrials.gov record NCT02638805. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label, Multi-Center, Randomized, Phase 3b Study to Evaluate the Safety and Tolerability of Switching to One of Two Dosing Strategies of ITCA 650 in Patients With Type 2 Diabetes Receiving Stable Doses of Liraglutide
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A Phase 3b, open-label, randomized, multicenter, safety and tolerability study of ITCA 650 in subjects with Type 2 diabetes taking liraglutide and metformin.
Study identification
- NCT ID
- NCT02638805
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 136 participants
Conditions and interventions
Conditions
Interventions
- ITCA 650 Osmotic Mini Pump 20/60 mcg/day Drug
- ITCA 650 Osmotic Mini Pump 60 mcg/day Drug
- Metformin Drug
- Liraglutide Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2015 (Type not available)
- Primary completion
- Oct 2017 (Actual)
- Completion
- Oct 2017 (Actual)
- Last update posted
- Nov 5, 2018
2015 – 2017
United States locations
- U.S. sites
- 36
- U.S. states
- 17
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alabama Clinical Therapeutics, LLC | Birmingham | Alabama | 35235 | — |
| Saint Vincent's Medical Center (BRANY) | Gulf Shores | Alabama | 36542 | — |
| Arkansas Primary Care Clinic, PA | Little Rock | Arkansas | 72204 | — |
| University of Colorado Hospital | Aurora | Colorado | — | — |
| Denver VA Medical Center | Denver | Colorado | 80220 | — |
| Meridien Research | Brooksville | Florida | 34601 | — |
| International Research Associates, LLC | Hialeah | Florida | 33012 | — |
| Care Partners Clinical Research, LLC | Jacksonville | Florida | 32218 | — |
| AMPM Research Clinic | Miami | Florida | 33145 | — |
| Epocrates Medical and Research Center | Miami | Florida | 33175 | — |
| Sensible Healthcare, LLC | Ocoee | Florida | 34761 | — |
| Solaris Clinical Research | Meridian | Idaho | 83646 | — |
| American Health Network of Indiana, LLC | Avon | Indiana | 46123 | — |
| American Health Network of Indiana, LLC | Franklin | Indiana | 46131 | — |
| American Health Network of Indiana, LLC | Greenfield | Indiana | 46140 | — |
| Cotton-O'Neil Clinical Research Center | Topeka | Kansas | 66606 | — |
| University of Massachusetts Medical School | Worcester | Massachusetts | 01655 | — |
| Center for Advanced Medical Research | City of Saint Peters | Missouri | 63303 | — |
| Radiant Research | St Louis | Missouri | 63141 | — |
| Accent Clinical Trials | Las Vegas | Nevada | 89119 | — |
| Palm Research Center, Inc. | Las Vegas | Nevada | 89148 | — |
| Manhattan Medical Research | New York | New York | 10016 | — |
| Novel Research of New York | The Bronx | New York | 10461 | — |
| Carteret Medical Group, LLC | Morehead City | North Carolina | 28557 | — |
| Prestige Clinical Research | Franklin | Ohio | 45005 | — |
| Lynn Institute of the Oz | Norman | Oklahoma | 73069 | — |
| LION Research | Norman | Oklahoma | 73072 | — |
| University of Tennessee Health Sciences Center | Memphis | Tennessee | 38103 | — |
| Coastal Bend Clinical Research | Corpus Christi | Texas | 78414 | — |
| Dallas Diabetes and Endocrine Center | Dallas | Texas | 75230 | — |
| Juno Research, LLC | Houston | Texas | 77036 | — |
| Sante Clinical Research | Kerrville | Texas | 78028 | — |
| Panacea Clinical Research, LLC | San Antonio | Texas | 78228 | — |
| Clinical Trials of Texas, Inc. | San Antonio | Texas | 78229 | — |
| Victorium Clinical Research Ltd. | San Antonio | Texas | 78229 | — |
| Erickson Research and Development | Clinton | Utah | 84015 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02638805, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 5, 2018 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02638805 live on ClinicalTrials.gov.